Thats the best reading Chairman and MD report we have had. For any holders needing a sniff of optimism read those twice and look to the next 6 months. Very positive language regarding Fuji, specifically mentions big pharma and 3 new customers on line by the end of year plus acknowledgement of the "Achilles heal" referring to the share price.
Some further funding required but with a solid R and D refund coming and increasing sales any raise will be at a much better price.
Great reading.
Ann: FY23 Annual Report, page-5
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.728M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5440010 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 1445039 | 3 |
View Market Depth
| Last trade - 16.18pm 30/08/2024 (20 minute delay) ? |
| BCT (ASX) Chart |
Day chart unavailable